We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$540M
Turnover
8.47%
1-Year Est. Return
15.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+15.41%
3 Year Est. Return
+78.2%
5 Year Est. Return
+77.01%
10 Year Est. Return
+368.49%
AUM
$216M
AUM Growth
-$7.9M
(-3.5%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
41.54%
Holding
102
New
6
Increased
52
Reduced
19
Closed
3
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$6.38M |
| 2 |
Medtronic
MDT
|
+$743K |
| 3 |
Pentair
PNR
|
+$649K |
| 4 |
AbbVie
ABBV
|
+$319K |
| 5 |
IBM
IBM
|
+$302K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$9.75M |
| 2 |
Baxter International
BAX
|
+$4.48M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$4.35M |
| 4 |
Lowe's Companies
LOW
|
+$371K |
| 5 |
Omnicom Group
OMC
|
+$324K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.19% |
| 2 | Technology | 15.51% |
| 3 | Financials | 15.01% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
DELISTED
Walgreens Boots Alliance
WBA
| $503K | 0.23% |
6,044
+4
| +0.1% | +$323 |
2013 Q2
12 quarters
|
|
52
Intuitive Surgical
ISRG
$151B
| $501K | 0.23% |
6,822
| – | – |
2013 Q2
12 quarters
|
|
53
Waste Management
WM
$90.7B
| $478K | 0.22% |
7,217
+947
| +15% | +$57.2K |
2016 Q1
1 quarter
|
|
54
General Mills
GIS
$17.7B
| $449K | 0.21% |
6,300
| – | – |
2013 Q2
12 quarters
|
|
55
Pfizer
PFE
$169B
| $443K | 0.2% |
13,275
+1,952
| +17% | +$62.3K |
2013 Q3
11 quarters
|
|
56
Agnico Eagle Mines
AEM
$96B
| $428K | 0.2% |
8,000
| – | – |
2015 Q1
5 quarters
|
|
57
Costco
COST
$438B
| $427K | 0.2% |
2,717
| – | – |
2013 Q2
12 quarters
|
|
58
Merck
MRK
$360B
| $427K | 0.2% |
7,774
-378
| -5% | -$20.1K |
2013 Q2
12 quarters
|
|
59
Colgate-Palmolive
CL
$75B
| $410K | 0.19% |
5,600
| – | – |
2013 Q2
12 quarters
|
|
|
BPL
60
DELISTED
Buckeye Partners, L.P.
BPL
| $404K | 0.19% |
5,750
-2,000
| -26% | -$140K |
2013 Q2
12 quarters
|
|
61
SLB Ltd
SLB
$73.5B
| $399K | 0.18% |
5,050
| – | – |
2014 Q3
7 quarters
|
|
62
DELISTED
Spectra Energy Corp Wi
SE
| $397K | 0.18% |
10,832
+1,300
| +14% | +$41.4K |
2016 Q1
1 quarter
|
|
63
PPG Industries
PPG
$23.9B
| $385K | 0.18% |
3,700
| – | – |
2013 Q2
12 quarters
|
|
64
Conagra Brands
CAG
$6.91B
| $384K | 0.18% |
10,334
+2,920
| +39% | +$104K |
2016 Q1
1 quarter
|
|
65
UnitedHealth
UNH
$360B
| $371K | 0.17% |
2,625
+250
| +11% | +$33.3K |
2015 Q4
2 quarters
|
|
66
Xylem
XYL
$24.3B
| $368K | 0.17% |
8,250
+1,250
| +18% | +$54.3K |
2016 Q1
1 quarter
|
|
67
Coca-Cola
KO
$404B
| $353K | 0.16% |
7,777
+100
| +1% | +$4.52K |
2013 Q2
12 quarters
|
|
68
Meta Platforms (Facebook)
META
$1.81T
| $349K | 0.16% |
3,050
-500
| -14% | -$57.6K |
2016 Q1
1 quarter
|
|
|
ISBC
69
DELISTED
Investors Bancorp, Inc.
ISBC
| $346K | 0.16% |
31,202
| – | – |
2014 Q4
6 quarters
|
|
|
Y
70
DELISTED
Alleghany Corp
Y
| $341K | 0.16% |
620
+110
| +22% | +$57.3K |
2016 Q1
1 quarter
|
|
71
Gilead Sciences
GILD
$194B
| $336K | 0.16% |
4,022
+600
| +18% | +$53.2K |
2014 Q2
8 quarters
|
|
72
Public Service Enterprise Group
PEG
$35.6B
| $333K | 0.15% |
7,145
+2,145
| +43% | +$97.3K |
2016 Q1
1 quarter
|
|
73
Home Depot
HD
$309B
| $326K | 0.15% |
2,555
+150
| +6% | +$19.8K |
2013 Q3
11 quarters
|
|
|
74
AbbVie
ABBV
$504B
| $325K | 0.15% |
+5,242
| New | +$319K |
2016 Q2
0 quarters
|
|
75
Fluor
FLR
$6.28B
| $321K | 0.15% |
6,505
+902
| +16% | +$46.9K |
2016 Q1
1 quarter
|
|
Similar funds
DF
NQWM
ACM
MLIC
CAM
MWM
WWMSC
VCM
McRae Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, McRae Capital Management held 102 positions worth $216M, down 3.5% from $224M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
McRae Capital Management withdrew a net $8.39M in Q2 2016, closing 3 positions and reducing 19 holdings. Its most notable exit was Travelers Companies, an estimated $9.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, McRae Capital Management opened a new position in Labcorp worth $6.63M.
- McRae Capital Management's largest Q2 2016 buy was Labcorp: 59,253 shares worth $6.63M.
- McRae Capital Management added most to Medtronic in Q2 2016, an estimated $743K increase.
- McRae Capital Management's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $371K.
- McRae Capital Management fully exited Travelers Companies in Q2 2016, selling an estimated $9.75M.
- McRae Capital Management's ten largest holdings make up 42% of its $216M portfolio in Q2 2016.
- McRae Capital Management opened 6 new positions and closed 3 in Q2 2016.
- McRae Capital Management's portfolio value fell 3.5% quarter-over-quarter to $216M.
Based on McRae Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.